Religare Enterprises has set a price band of Rs 160-185 per share for its initial public offer, the financial services firm said in a statement.
At upper end of the band, the firm, which is selling 7.57 million shares, would raise Rs 1.4 billion ($35 million).
Enam Financial Consultants and Citigroup are advising Religare, founded by the the owners of Ranbaxy Laboratories.Merrill Lynch has bought a 5 per cent stake in the firm.
Related Posts:
Merill arm buy 5% in Religare
Macquarie Bank buys 50% in Religare`s wealth management
No comments:
Post a Comment